Clinical trial
Experience of PLUVICTO (PSMA-617 Labelled With Lutetium-177) Administration on Totally Implantable Venous Access Port (TIVAP)
NCT06858995 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Experience of PLUVICTO (PSMA-617 Labelled With Lutetium-177) Administration on Totally Implantable Venous Access Port (TIVAP)
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 5, 2025
- Completion date
- July 30, 2025
- Enrollment
- 107 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
administration of therapy